Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Apr;65(4 Spec No):349–351. doi: 10.1136/adc.65.4_spec_no.349

Alfentanil pharmacokinetics in preterm infants.

N Marlow 1, A M Weindling 1, A Van Peer 1, J Heykants 1
PMCID: PMC1590140  PMID: 2337359

Abstract

The pharmacokinetics of alfentanil were studied during the first four days after birth in 22 ventilated preterm infants who were all receiving muscle relaxants. Five minutes after a single dose of 20 micrograms/kg alfentanil median serum concentration was 66 ng/ml (range: 20-606). The median clearance was 0.87 ml/kg/min (range: 0.4-9.62) and median elimination half life 321 mins (64-1251). There were wide differences in the manner in which individual infants handled the drug and transient depression of blood pressure and heart rate was observed. These data were used to calculate an infusion dosage. In four infants 20 micrograms/kg alfentanil given by infusion over 30 minutes followed by 5 micrograms/kg/hour produced steady state median alfentanil concentrations of 54.5 ng/ml (range: 7-73 ng/ml) with no evidence of drug accumulation.

Full text

PDF
350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand K. J., Hickey P. R. Pain and its effects in the human neonate and fetus. N Engl J Med. 1987 Nov 19;317(21):1321–1329. doi: 10.1056/NEJM198711193172105. [DOI] [PubMed] [Google Scholar]
  2. Anand K. J., Sippell W. G., Schofield N. M., Aynsley-Green A. Does halothane anaesthesia decrease the metabolic and endocrine stress responses of newborn infants undergoing operation? Br Med J (Clin Res Ed) 1988 Mar 5;296(6623):668–672. doi: 10.1136/bmj.296.6623.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Greeley W. J., de Bruijn N. P. Changes in sufentanil pharmacokinetics within the neonatal period. Anesth Analg. 1988 Jan;67(1):86–90. [PubMed] [Google Scholar]
  4. Koehntop D. E., Rodman J. H., Brundage D. M., Hegland M. G., Buckley J. J. Pharmacokinetics of fentanyl in neonates. Anesth Analg. 1986 Mar;65(3):227–232. [PubMed] [Google Scholar]
  5. Lynn A. M., Slattery J. T. Morphine pharmacokinetics in early infancy. Anesthesiology. 1987 Feb;66(2):136–139. doi: 10.1097/00000542-198702000-00005. [DOI] [PubMed] [Google Scholar]
  6. Marlow N., Weindling A. M., Cooke R. W. Hazards of analgesia for newborn infants. Arch Dis Child. 1988 Oct;63(10):1293–1293. doi: 10.1136/adc.63.10.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Meistelman C., Saint-Maurice C., Lepaul M., Levron J. C., Loose J. P., Mac Gee K. A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology. 1987 Jan;66(1):13–16. doi: 10.1097/00000542-198701000-00003. [DOI] [PubMed] [Google Scholar]
  8. Michiels M., Hendriks R., Heykants J. Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in man. J Pharm Pharmacol. 1983 Feb;35(2):86–93. doi: 10.1111/j.2042-7158.1983.tb04275.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES